iCAD, INC. (NASDAQ:ICAD)
CAPS Rating:
The Company designs, develops, manufactures and markets Computer-Aided Detection solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier.
RSS Headlines
Fool UK
Recs
As a cancer survivor, any comany that is trying to pinpoint cancer earlier and identify pathologies gets a KUDOS or two from me. We are starting to spend more money on cancer research and treatment and if someone can make a break through then great. If not, we eliminated one wrong step and made another leap.